abstract |
The present invention provides a compound of formula (I) or a pharmaceutically acceptable salt or solvate thereof. These compounds are useful for treating disease states induced by VR1 receptor overactivation, such as pain in mammals. The present invention further provides a pharmaceutical composition comprising the compound. [Chemical 1] |